Trial Profile
Use of Mucomyst (NAC) to Ameliorate Oxidant Stress in Diabetic Patients as Measurable by Surrogate Serum Markers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 07 Oct 2015 New trial record